Sale

Analgesics Market

Global Analgesics Market Share, Size, Growth, Analysis: By Type: Prescription Analgesics, OTC Analgesics; By Drug Class: Opioids, NSAID, Others; By Route of Administration: Oral, Parenteral, Topical, Transdermal, Rectal; By Pain Type: Musculoskeletal Pain, Others; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Analgesics Market Outlook 

The global analgesics market size attained a value of USD 71.90 billion in 2023 driven by increasing cases of chronic pain due to the rising old age population past 60 years of age. The market is anticipated to grow at a CAGR of 4.5% during the forecast period of 2024-2032 to attain a value of USD 106.84 billion by 2032.

 

Analgesics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global analgesics market is driven by the increasing geriatric population globally. In 2017, the people over the age of 60, were recorded to be 950-1000 million. By the year 2050, these numbers are expected to grow rapidly to reach 2100 million, accounting for about 21% of the overall global population. Due to their susceptibility to chronic and lifestyle diseases, the rising population of older people will substantially contribute to the sales of analgesics. Further, permission by the United States Food and Drug Administration (USFDA) for the utilisation of a strong drug pipeline with efficacious drugs is expected to aid the analgesics market growth in the forecast period.

 

Analgesics Market by Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Analgesics is referred to as a type of drug intended to relieve or control pain. Several of these drugs work on the body’s peripheral and central nervous systems to mitigate or block sensitivity to pain. However, some of the analgesics act by inhibiting the formation of certain chemicals in the body that mediate pain. These painkillers are prescription-only medicines, available only on doctor’s instruction and recommendation. These are used to treat moderate to severe pain, including backache, along with neck, pre-menstrual and menstrual, and muscle pain.

The analgesics market is divided on the basis of type into:

  • Prescription Analgesics
  • OTC Analgesics

On the basis of drug class, the analgesics market is divided into:

  • Opioids
  • NSAID
  • Others

On the basis of ROA, the analgesics market is segmented into:

  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal

On the basis of pain type, the analgesics market is divided into:

  • Musculoskeletal Pain
  • Surgical and Trauma Pain
  • Cancer Pain
  • Neuropathic Pain
  • Migraine
  • Obstetrical Pain
  • Fibromyalgia
  • Pain due to Burns
  • Dental/Facial Pain
  • Paediatric Pain
  • Others

On the basis of application, the analgesics market is bifurcated into:

  • Internal Analgesics
  • External Analgesics

The report also covers the regional analgesics markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Analgesics Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global analgesics market is driven by the increasing cases of chronic pain due to the rising old age population past 60 years of age. The growing proportion of older people will contribute significantly to the sales of analgesics. In addition to this, healthcare companies are investing in research and development activities to advance the combination of existing compounds to develop novel analgesics with enhanced efficacy and reduced side effects. Furthermore, with the launch of a national education campaign by the United States Food and Drug Administration (USFDA) to offer guidance to patients and create awareness among the patients about the safe use of OTC analgesics, has resulted in the increased demand for these medicines, thereby propelling the industry growth in the region.

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the global analgesics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Bayer AG  
  • GlaxoSmithKline PLC 
  • Pfizer Inc. 
  • Sanofi 
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Drug Class
  • Route of Administration
  • Pain Type
  • Application
  • End User
  • Region
Breakup by Type
  • Prescription Analgesics
  • OTC Analgesics
Breakup by Drug Class
  • Opioids
  • NSAID
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal
Breakup by Pain Type
  • Musculoskeletal Pain
  • Surgical and Trauma Pain
  • Cancer Pain
  • Neuropathic Pain
  • Migraine
  • Obstetrical Pain
  • Fibromyalgia
  • Pain due to burns
  • Dental/Facial Pain
  • Pediatric Pain
  • Others
Breakup by Application
  • Internal Analgesics
  • External Analgesics
Breakup by End User
  • Hospital Pharmacy
  • Retail Pharmacy
  • Other
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Bayer AG
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Sanofi
  • F. Hoffmann-La Roche Ltd.
  • Endo Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Assertio Therapeutics, Inc.
  • Janssen Pharmaceuticals
  • Novartis AG
  • Teva Pharmaceuticals
  • AbbVie Inc.
  • Purdue Pharmaceuticals L.P.
  • Boehringer Ingelheim International GmbH

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Analgesics Market Overview 

    3.1    Global Analgesics Market Historical Value (2017-2023)
    3.2    Global Analgesics Market Forecast Value (2024-2032)
4    Global Analgesics Market Landscape
    4.1    Global Analgesics Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Analgesics Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Drug Class
        4.2.3    Analysis by Route of Administration
        4.2.4    Analysis by Pain Type
        4.2.5    Analysis by Application
        4.2.6    Analysis by Distribution Channel
5    Global Analgesics Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Analgesics Market Segmentation 
    6.1    Global Analgesics Market by Type
        6.1.1    Market Overview
        6.1.2    Prescription Analgesics
        6.1.3    OTC Analgesics
    6.2    Global Analgesics Market by Drug Class
        6.2.1    Market Overview
        6.2.2    Opioids
        6.2.3    NSAID
        6.2.4    Others
    6.3    Global Analgesics Market by Route of Administration
        6.3.1    Market Overview
        6.3.2    Oral
        6.3.3    Parenteral
        6.3.4    Topical
        6.3.5    Transdermal
        6.3.6    Rectal
    6.4    Global Analgesics Market by Pain Type
        6.4.1    Market Overview
        6.4.2    Musculoskeletal Pain
        6.4.3    Surgical and Trauma Pain
        6.4.4    Cancer Pain
        6.4.5    Neuropathic Pain
        6.4.6    Migraine
        6.4.7    Obstetrical Pain
        6.4.8    Fibromyalgia
        6.4.9    Pain due to burns
        6.4.10    Dental/Facial Pain
        6.4.11    Pediatric Pain
        6.4.12    Others
    6.5    Global Analgesics Market by Application
        6.5.1    Market Overview
        6.5.2    Internal Analgesics
        6.5.3    External Analgesics 
    6.6    Global Analgesics Market by End User
        6.6.1    Market Overview
        6.6.2    Hospital Pharmacy
        6.6.3    Retail Pharmacy
        6.6.4    Other
    6.7    Global Analgesics Market by Region
        6.7.1    Market Overview
        6.7.2    North America 
        6.7.3    Europe
        6.7.4    Asia Pacific
        6.7.5    Latin America
        6.7.6    Middle East and Africa
7    North America Analgesics Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Analgesics Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Analgesics Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Analgesics Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Analgesics Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Bayer AG
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    GlaxoSmithKline plc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Pfizer Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Sanofi
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    F. Hoffmann-La Roche Ltd.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Endo Pharmaceuticals, Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Bristol-Myers Squibb Company
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Assertio Therapeutics, Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Janssen Pharmaceuticals
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Novartis AG
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Teva Pharmaceuticals
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    AbbVie Inc.
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Purdue Pharmaceuticals L.P.
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    Boehringer Ingelheim International GmbH
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
18    Global Analgesics Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

Globally, analgesics market reached a value of USD 71.90 billion in 2023.

The market is projected to expand at a CAGR of 4.5% from 2024 to 2032, growing to USD 106.84 billion by 2032.

The major drivers of the industry such as rising disposable incomes, increasing population, increasing health consciousness, and increasing geriatric population are expected to aid the industry growth.

The rising R&D activities aimed at producing more effective analgesics with lesser side effects is a major trend guiding the growth of the market.

The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The leading types of the product in the industry are prescription and OTC analgesics.

Opioids and NSAID, among others, are the leading drug classes available in the market.

The leading ROA types in the industry are into oral, parenteral, topical, transdermal, and rectal.

The major pain types covered in the report are musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine, obstetrical pain, fibromyalgia, pain due to burns, dental/facial pain, paediatric pain, and others.

The leading applications of the product are internal and external analgesics.

The major players in the industry are Bayer AG, GlaxoSmithKline PLC, Pfizer Inc., Sanofi, and others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER